Carcinoma Prostatico: Valutazione Ecografica Transrettale Del Trattamento Con Lh-Rh Analogo

Abstract

Get full access to this article

View all access options for this article.

References

Ahmed

S. R.

, Grant

, Sholet

S. M.

: Preliminary report on use of depot formulation of LH-RH analogue ICI 118630 (Zoladex) in patients with prostatic cancer. Brit. Med. J., 280; 185 (1985).

Clayton

R. N.

, Catt

R. J.

: Gonadotropin releasing hormone receptors: characterization, physiological regulation and relationship to reproductive function. Endocrine Rev., 2; 186 (1981).

Corbin

: From contraception to cancer: a review of the therapeutic applications of LH-RH analogues as antitumor agents. Yale J. Biol. Med., 55; 27 (1982).

Hendwnd

P. O.

, Gustafsson

, Sjogren

: Cardio-vascular complications to treatment of prostatic cancer with estramustine phosphate or conventional estrogens. Scand. J. Urol. Nephrol., 55; Suppl., 103–105 (1980).

Jacobi

G. H.

, Wenderith

U. K.

: Gonadotropin releasing hormone analogues for prostatic cancer. Eur. Urol., 8; 129 (1982).

Labrie

, Lemany

: Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent LH-RH analogue on the rat prostate. J. Urol., 128; 1097 (1982).

Murphy

G. P.

, Natarajan

, Pontes

J. E.

: The national survey of prostate cancer in the United States by the American College of Surgeons. J. Urol., 127; 929 (1982).

Murphy

G. P.

, Grecoj

, Benn

R. P.

: Zoladex (ICI 118630): clinical trial of a LH-RH oneday in metastatic prostatic carcinoma. Urology, 29; 185–190 (1987).

Narayama

A.S.

, Loening

S.A.

, Culp

D.A.

: Flutamide in the treatment of metastatic carcinoma of the prostate. Brit. J. Urol., 53; 152 (1981).

10.

Schally

A.W.

, Arimura

: Isolation and properties of the FSH and LH releasing hormone. Biochem. Biophys. Res. Comm., 43; 393 (1971).

11.

Schally

A. W.

, Coy

D. H.

, Arimura

: LH-RH agonists and antiagonists. Intern. J. Gynaec, 18; 318 (1980).

12.

Trachtenberg

: The effect of the chronic administration of a potent luteinizing hormone analogue on the rat prostate. J. Urol., 128; 1097 (1982).

13.

Tvetar

K. J.

, Otmes

, Homestad

: Treatment of prostatic carcinoma with Cyproterone acetate. Scand. J. Urol. Nephrol., 12; 115 (1978).

14.

Waxaman

: Early tumor exacerbation in patients treated with long acting analogues of gonadotropin releasing hormone. Brit. Med. J., 292; 58 (1986).

15.

Wenderoth

U. K.

, Jacobi

U. K.

: Gonadotropin releasing hormone analogues for palliation of carcinoma of the prostate: a new approach to the clinical concept. World J. Urol., 1; 40 (1983).